beta-Galactosidase (E2U2I) Rabbit Monoclonal and 2 more items

The University of Nebraska Medical Center (UNMC), a state institution under the Board of Regents of the University of Nebraska, awarded a purchase order valued at $905 to Cell Signaling Technology Inc., a Boston, Massachusetts-based vendor, for the delivery of three rabbit monoclonal antibodies. The contract was issued on February 12, 2026, with a completion date of February 19, 2026. Performance of work is to be conducted in Omaha, Nebraska, where UNMC's Shipping and Receiving department is located. Payment terms are Net 30, with freight prepaid by the vendor under Free on Board (FOB) Destination terms, and the University's tax-exempt status applies to this transaction.

The specific line items procured include beta-Galactosidase (E2U2I) Rabbit Monoclonal Antibody at $351 per unit, p16 INK4A (F9T1L) Rabbit Monoclonal Antibody at $178 per unit, and MCT4/SLC16A3 (F2K6A) Rabbit Monoclonal Antibody at $376 per unit, with one unit ordered for each product. These research-grade antibodies are essential biochemical reagents utilized in laboratory and diagnostic applications. The purchase order requires vendor acknowledgment within ten days and mandates that the purchase order number appear on all packages, invoices, and related documentation.